164 related articles for article (PubMed ID: 19968886)
1. Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas.
Bruland O; Fluge Ø; Akslen LA; Eiken HG; Lillehaug JR; Varhaug JE; Knappskog PM
BMC Cancer; 2009 Dec; 9():425. PubMed ID: 19968886
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes.
Uutela M; Laurén J; Bergsten E; Li X; Horelli-Kuitunen N; Eriksson U; Alitalo K
Circulation; 2001 May; 103(18):2242-7. PubMed ID: 11342471
[TBL] [Abstract][Full Text] [Related]
3. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
Zhang H; Teng X; Liu Z; Zhang L; Liu Z
J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
[TBL] [Abstract][Full Text] [Related]
5. Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma.
Sheu SY; Vogel E; Worm K; Grabellus F; Schwertheim S; Schmid KW
Histopathology; 2010 Apr; 56(5):632-40. PubMed ID: 20459574
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
7. Expression microarray analysis of papillary thyroid carcinoma and benign thyroid tissue: emphasis on the follicular variant and potential markers of malignancy.
Finn SP; Smyth P; Cahill S; Streck C; O'Regan EM; Flavin R; Sherlock J; Howells D; Henfrey R; Cullen M; Toner M; Timon C; O'Leary JJ; Sheils OM
Virchows Arch; 2007 Mar; 450(3):249-60. PubMed ID: 17252232
[TBL] [Abstract][Full Text] [Related]
8. Gene expression in poorly differentiated papillary thyroid carcinomas.
Fluge Ø; Bruland O; Akslen LA; Lillehaug JR; Varhaug JE
Thyroid; 2006 Feb; 16(2):161-75. PubMed ID: 16676402
[TBL] [Abstract][Full Text] [Related]
9. Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.
Vasko V; Espinosa AV; Scouten W; He H; Auer H; Liyanarachchi S; Larin A; Savchenko V; Francis GL; de la Chapelle A; Saji M; Ringel MD
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2803-8. PubMed ID: 17296934
[TBL] [Abstract][Full Text] [Related]
10. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
Sheils OM; O'Leary JJ; Sweeney EC
J Pathol; 2000 Sep; 192(1):32-6. PubMed ID: 10951397
[TBL] [Abstract][Full Text] [Related]
11. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma.
Wagner PL; Moo TA; Arora N; Liu YF; Zarnegar R; Scognamiglio T; Fahey TJ
Ann Surg Oncol; 2008 Oct; 15(10):2833-41. PubMed ID: 18696160
[TBL] [Abstract][Full Text] [Related]
12. BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas.
Durante C; Tallini G; Puxeddu E; Sponziello M; Moretti S; Ligorio C; Cavaliere A; Rhoden KJ; Verrienti A; Maranghi M; Giacomelli L; Russo D; Filetti S
Eur J Endocrinol; 2011 Sep; 165(3):455-63. PubMed ID: 21653734
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma.
Yano Y; Uematsu N; Yashiro T; Hara H; Ueno E; Miwa M; Tsujimoto G; Aiyoshi Y; Uchida K
Clin Cancer Res; 2004 Mar; 10(6):2035-43. PubMed ID: 15041723
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Pathological Features and Gene Expression Profiles of Clinically Aggressive Papillary Thyroid Carcinomas.
Metovic J; Cabutti F; Osella-Abate S; Orlando G; Tampieri C; Napoli F; Maletta F; Daniele L; Volante M; Papotti M
Endocr Pathol; 2023 Sep; 34(3):298-310. PubMed ID: 37208504
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.
Rosignolo F; Maggisano V; Sponziello M; Celano M; Di Gioia CR; D'Agostino M; Giacomelli L; Verrienti A; Dima M; Pecce V; Durante C
J Endocrinol Invest; 2015 Dec; 38(12):1283-9. PubMed ID: 26003825
[TBL] [Abstract][Full Text] [Related]
16. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
[TBL] [Abstract][Full Text] [Related]
17. Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomas.
Schulten HJ; Alotibi R; Al-Ahmadi A; Ata M; Karim S; Huwait E; Gari M; Al-Ghamdi K; Al-Mashat F; Al-Hamour O; Al-Qahtani MH; Al-Maghrabi J
BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S6. PubMed ID: 25922907
[TBL] [Abstract][Full Text] [Related]
18. Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas.
Degl'Innocenti D; Alberti C; Castellano G; Greco A; Miranda C; Pierotti MA; Seregni E; Borrello MG; Canevari S; Tomassetti A
PLoS One; 2010 Sep; 5(9):e12701. PubMed ID: 20877637
[TBL] [Abstract][Full Text] [Related]
19. NATH, a novel gene overexpressed in papillary thyroid carcinomas.
Fluge Ø; Bruland O; Akslen LA; Varhaug JE; Lillehaug JR
Oncogene; 2002 Aug; 21(33):5056-68. PubMed ID: 12140756
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment.
Moretti S; Menicali E; Voce P; Morelli S; Cantarelli S; Sponziello M; Colella R; Fallarino F; Orabona C; Alunno A; de Biase D; Bini V; Mameli MG; Filetti S; Gerli R; Macchiarulo A; Melillo RM; Tallini G; Santoro M; Puccetti P; Avenia N; Puxeddu E
J Clin Endocrinol Metab; 2014 May; 99(5):E832-40. PubMed ID: 24517146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
